In this review we discuss the contribution of NO, prostacyclin and endotheliumderived
relaxing factor—endothelium-derived hyperpolarizing factor, or EDHF, to vascular function …

Endothelial dysfunction is considered as a major risk factor of cardiovascular complications
of type I and types II diabetes. Impaired endothelium-dependent vasodilatation can be …

Nitric oxide (NO), together with prostacyclin (PGI2), mediates shear stress and endothelium-
dependent vasodilator-mediated vasorelaxation. In the presence of inhibition of NO …

Vascular endothelial cells release a variety of vasorelaxant factors in response to stretch or
to agonists. Attention has mainly focused on two such factors, prostacyclin and nitric oxide …

The endothelium controls vascular tone not only by releasing nitric oxide (NO) and
prostacyclin but also by other pathways causing hyperpolarization of the underlying smooth …

The endothelium plays an important role in maintaining vascular homeostasis by
synthesizing and releasing several endothelium-derived relaxing factors, such as …

Endothelium plays a crucial role in the regulation of cardiovascular homeostasis through the
release of vasoactive factors. Besides nitric oxide (NO) and prostacyclin, increasing …

Vascular endothelium plays an important role in maintaining vascular homeostasis by
synthesizing and releasing several vasodilating factors, such as prostacyclin, nitric oxide …

Vascular endothelium plays an important role in maintaining vascular homeostasis by
synthesizing and releasing several vasodilating factors, such as prostacyclin, nitric oxide …

In addition to nitric oxide (NO) and prostacyclin (PGI2), the endothelium generates the
endothelium-derived hyperpolarizing factor (EDHF). We set out to determine whether an …